These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36069924)

  • 1. Growing Role of Gabapentin in Opioid-Related Overdoses Highlights Misuse Potential and Off-label Prescribing Practices.
    Kuehn BM
    JAMA; 2022 Oct; 328(13):1283-1285. PubMed ID: 36069924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin and pregabalin: do the benefits outweigh the harms?
    Morrison EE; Sandilands EA; Webb DJ
    J R Coll Physicians Edinb; 2017 Dec; 47(4):310-313. PubMed ID: 29537399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults.
    Toce MS; Michelson KA; Hudgins JD; Hadland SE; Olson KL; Monuteaux MC; Bourgeois FT
    Ann Emerg Med; 2023 Apr; 81(4):429-437. PubMed ID: 36669914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Diagram of the Social-Ecological Conditions of Opioid Misuse and Overdose.
    Brady BR; Taj EA; Cameron E; Yoder AM; De La Rosa JS
    Int J Environ Res Public Health; 2023 Oct; 20(20):. PubMed ID: 37887688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The salience of social context, opioid antagonist use, and prior opioid exposure as determinants of fatal and non-fatal opioid overdoses.
    Zimmerman GM; Douglas SD; Turchan BS; Braga AA
    Health Place; 2023 Jan; 79():102970. PubMed ID: 36638643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer.
    Winn AN; Check DK; Farkas A; Fergestrom NM; Neuner JM; Roberts AW
    JAMA Netw Open; 2020 Sep; 3(9):e2016858. PubMed ID: 32930779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
    Alexander GC; Ballreich J; Mansour O; Dowdy DW
    Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons.
    Weisberg DF; Becker WC; Fiellin DA; Stannard C
    Int J Drug Policy; 2014 Nov; 25(6):1124-30. PubMed ID: 25190034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staring down the opioid epidemic.
    Unger JR
    J Fam Pract; 2017 Jan; 66(1):8. PubMed ID: 28188310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin misuse.
    Lennox R; Mangin D
    CMAJ; 2019 Jan; 191(2):E47. PubMed ID: 30642825
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid Misuse: A Review of the Main Issues, Challenges, and Strategies.
    Biancuzzi H; Dal Mas F; Brescia V; Campostrini S; Cascella M; Cuomo A; Cobianchi L; Dorken-Gallastegi A; Gebran A; Kaafarani HM; Marinangeli F; Massaro M; Renne A; Scaioli G; Bednarova R; Vittori A; Miceli L
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36142028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort study of new off-label gabapentin prescribing in chronic opioid users.
    Billig JI; Bicket MC; Yazdanfar M; Gunaseelan V; Sears ED; Brummett CM; Waljee JF
    Reg Anesth Pain Med; 2024 Feb; 49(2):88-93. PubMed ID: 37380198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descriptions of Gabapentin Misuse and Associated Behaviors among a Sample of Opioid (Mis)users in South Florida.
    Buttram ME; Kurtz SP
    J Psychoactive Drugs; 2021; 53(1):47-54. PubMed ID: 32748701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
    Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
    Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system.
    Campbell CI; Bahorik AL; VanVeldhuisen P; Weisner C; Rubinstein AL; Ray GT
    Prev Med; 2018 May; 110():31-37. PubMed ID: 29410132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coprescription of Opioids With Other Medications and Risk of Opioid Overdose.
    Khan NF; Bykov K; Glynn RJ; Barnett ML; Gagne JJ
    Clin Pharmacol Ther; 2021 Oct; 110(4):1011-1017. PubMed ID: 34048030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ethnographic decision model of the initiation of gabapentin misuse among prescription and/or illicit opioid (mis)user.
    Buttram ME; Kurtz SP; Cicero TJ; Havens JR
    Drug Alcohol Depend; 2019 Nov; 204():107554. PubMed ID: 31542629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.